Prostate Cancer Modeling
The CISNET Prostate Working Group (PWG) is in its fourth round of funding. The group has focused on modeling prostate cancer progression, screening, and treatment in the U.S. population, assuming biologically plausible assumptions validated against various data sources. In the current round, the PWG is examining efficiency gains of screening only high-risk individuals, benefits of avoiding or delaying treatment for low-risk cancers, and feasible approaches for reducing racial disparities. This research will advance the evidence necessary to make informed decisions about screening and treatment for this most common cancer in men.